Document is current
Any future updates will be listed below
-
Authors
Wisse, P. H. A.
de Klaver, W.
van Wifferen, F.
Meiqari, L.
Bierkens, M.
Greuter, M. J. E.
Carvalho, B.
van Leerdam, M. E.
Spaander, M. C. W.
Dekker, E.
Coupé, V. M. H.
de Wit, M.
Meijer, G. A.
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding / Stand Up To Cancer (SU2C-AACR-DT1415)
Health~Holland (LSHM 15040, LSHM18032-SGF, LSHM21042-H027)
- License Information
-
More Information
Article History
Received: 8 September 2022
Accepted: 24 November 2022
First Online: 12 December 2022
Declarations
:
: The Dutch Ministry of Health, Welfare and Sport granted the ethical approval on May 20, 2020 (reference number 1691110-204907-PG).Participants gave informed consent to participate in the study.
: Not applicable.
: GAM is co-founder and board member (CSO) of CRCbioscreen BV, he has a research collaboration with CZ Health Insurances (cash matching to ZonMW grant) and he has research collaborations with Exact Sciences, Sysmex, Sentinel Ch. SpA, Personal Genome Diagnostics (PGDX), DELFi and Hartwig Medical Foundation; these companies provide materials, equipment and/or sample/genomic analyses.MdW is co-founder and board member (COO) of CRCbioscreen BV. MCWS has received research support from: Sentinel, Sysmex, Norgine, and Medtronic. ED has endoscopic equipment on loan of Olympus and FujiFilm, and received a research grant from FujiFilm. She has received honorarium for consultancy from FujiFilm, Tillots, Olympus, GI Supply, Cancer Prevention Pharmaceuticals, PAION and Ambu, and speakers' fees from Olympus, Roche, GI Supply, Norgine, IPSEN, PAION and FujiFilm. BC, MdW, VMHC and GAM have several patents pending and/or issued.
